Minamitani Masanari, Mukai Tomoya, Tatemichi Masayuki, Katano Atsuto, Fukuyoshi Jun, Nakagawa Keiichi
Department of Comprehensive Radiation Oncology, The University of Tokyo.
Graduate Schools for Law and Politics, The University of Tokyo.
Sangyo Eiseigaku Zasshi. 2023 Sep 25;65(5):231-247. doi: 10.1539/sangyoeisei.2022-022-B. Epub 2023 Mar 25.
Most cancer control measures in the workplace have limited supporting evidence. This study aimed to identify highly effective cancer control measures, based on a survey by the Corporate Action to Promote Cancer Control.
The firms and organizations that responded to the web survey were included. The questionnaire comprised five cancer (stomach, lung, colorectal, breast, and cervical) screening rates and their countermeasures to promote cancer control. We conducted a non-hierarchical cluster analysis according to the degree of the measures and compared the screening rates among each group using an analysis of variance. Then, we performed two multiple regression analyses with the mean screening rates for stomach/lung/colorectal cancer and breast/cervical cancer as dependent variables, the implementation of each countermeasure as an independent variable, and the size and industry as control variables.
We obtained responses from 704 firms and organizations. The three groups classified by cluster analysis were defined as active, moderate, and negative. For all cancer screenings, the main effects were significant, and multiple comparisons revealed that the difference between the active and negative groups (ts > 3.30, ps < .01, Hedges' ds > 0.73) and the moderate and negative groups (ts > 3.70, ps < .01, Hedges' ds > 0.88) were significant. For the four cancers other than lung, the difference between the active and moderate groups was not significant (ts < 0.21, ps < .84, Hedges' ds < 0.02), and for lung, the difference was significant, but the effect size was small. The multiple regression analyses revealed that "distribution of colorectal cancer test kits to all subjects" (β = 0.14) was significant for stomach, lung, and colorectal cancer, while "financial supports for cancer screening" (β = 0.24), "screening as part of employment" (β = 0.18), and "careful screening of female subjects" (β = 0.17) were significant for breast and cervical cancer, respectively.
We identified effective countermeasures for cancer control in the workplace, and these measures will help increase cancer screening rates.
职场中大多数癌症控制措施的支持证据有限。本研究旨在基于促进癌症控制企业行动的一项调查,确定高效的癌症控制措施。
纳入对网络调查做出回应的公司和组织。问卷包括五种癌症(胃癌、肺癌、结直肠癌、乳腺癌和宫颈癌)的筛查率及其促进癌症控制的对策。我们根据措施的程度进行非层次聚类分析,并使用方差分析比较各组之间的筛查率。然后,我们进行了两次多元回归分析,以胃癌/肺癌/结直肠癌和乳腺癌/宫颈癌的平均筛查率为因变量,每项对策的实施情况为自变量,规模和行业为控制变量。
我们收到了704家公司和组织的回复。聚类分析划分出的三组被定义为积极组、中等组和消极组。对于所有癌症筛查,主效应显著,多重比较显示积极组和消极组之间的差异(ts>3.30,ps<.01,Hedges'ds>0.73)以及中等组和消极组之间的差异(ts>3.70,ps<.01,Hedges'ds>0.88)显著。对于除肺癌外的四种癌症,积极组和中等组之间的差异不显著(ts<0.21,ps<.84,Hedges'ds<0.02),对于肺癌,差异显著,但效应量较小。多元回归分析显示,“向所有对象发放结直肠癌检测试剂盒”(β=0.14)对胃癌、肺癌和结直肠癌具有显著意义,而“癌症筛查的资金支持”(β=0.24)、“就业体检”(β=0.18)和“对女性对象的仔细筛查”(β=0.17)分别对乳腺癌和宫颈癌具有显著意义。
我们确定了职场中有效的癌症控制对策,这些措施将有助于提高癌症筛查率。